Turnover: 402 million EUR (2022)

Country: France

Stago was originally a pharmaceutical laboratory created in 1945. The company gradually turned to the In Vitro Diagnostics (IVD) industry and is now the French leader in the field of hemostasis and thrombosis.

In 2017, Hemosonics joined the Stago Group to offer a new approach to delocalized POC biology, distributed in France and Belgium by its new subsidiary Stago BioCare.

Financial Data

DUNS: 305151409

Legal Name: DIAGNOSTICA STAGO

Address: 3 ALL THERESA , 92600 ASNIERES-SUR-SEINE

Number of employees: 1217 (2017)

Capital: 7 509 445


Financial Data:

Year Turnover (€) Net Profit (€) Fiscal Year End Fiscal Year Duration
2018 320 015 361 EUR 27 274 759 EUR 31/12/2018 12
2017 347 702 030 EUR 51 329 455 EUR 31/12/2017 12
2016 332 684 463 EUR 47 100 436 EUR 31/12/2016 12
2015 326 866 435 EUR 46 258 384 EUR 31/12/2015 12

Company Managers:

Position First Name Last Name Age Linkedin
Président Jean-Claude PIEL 65
Directeur général délégué Patrick MONNOT 70
Directeur général délégué Antoine COULOT 63

Studies mentioning this company

The in vitro diagnostics market - France

Other companies mentioned:

  • Roche Groupe
  • Diagast
  • Abbott Groupe
  • Danaher
  • Thermo Fisher Diagnostics
  • Sebia
  • BioMerieux Groupe
  • Diagnostica Stago
  • Biosynex
  • Diagnostic Medical System DMS

> Besoin de plus d'information sur cette entreprise (SWOT, PESTEL, son marché) ? Demandez à SectorGPT (gratuit)

 

Ask Sector-GPT  

Sector-GPT est la première IA dédiée aux informations sectorielles.